Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments

Immunotherapy that has proven efficacy in several solid cancers plays a partial role in improving clinical outcomes of advanced gastrointestinal (GI) cancers. There is an unmet need to find new immune-related therapeutic targets. Doublecortin-like kinase 1 (DCLK1) marks tuft cells which are recogniz...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiangyan, Qu, Dongfeng, Weygant, Nathaniel, Peng, Jun, Houchen, Courtney W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073156/
https://www.ncbi.nlm.nih.gov/pubmed/31979136
http://dx.doi.org/10.3390/cancers12020274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073156/
https://www.ncbi.nlm.nih.gov/pubmed/31979136
http://dx.doi.org/10.3390/cancers12020274

Ejemplares similares